Canaccord Ups Price Target on XOMA, Ltd. (XOMA), sees "Progress" in Trials

Article Stock Quotes (1) Comments (0)

Today Canaccord Genuity maintained a Hold rating on XOMA, Ltd. (NASDAQ: XOMA) and raised the price target to $3.00 (from $2.00).

Analysts Ritu Baral likes second quarter progress for Ph3 uveitis, Ph2 severe acne, other trials.

"Our $3 target is based on a pNPV analysis," said Raral.

For an analyst ratings summary and ratings history on XOMA, Ltd. click here. For more ratings news on XOMA, Ltd. click here.

Shares of XOMA, Ltd. closed at $3.18 yesterday, with a 52 week range of $1.04-$4.13.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
• Goldman Sachs Starts Quintiles (Q) at Neutral
• UPDATE: Oppenheimer Upgrades GameStop (GME) to Outperform

Create E-mail Alert Related Categories

Analyst Comments, Analyst PT Change

Related Entities

Canaccord Genuity

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?